Showing results (1821-1830 of 2,023) with videos related to

Sort By:
Pageof 203
Molecular Cancer Therapeutics|September 1, 2011
Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiationAnja Uhmann, Hannah Niemann, Bérénice Lammering, et al.
Scientific Reports|February 25, 2021
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSinead M O'Donovan, Ali Imami, Hunter Eby, et al.
Plos One|July 2, 2016
Identification of Shell Colour Pigments in Marine Snails Clanculus pharaonius and C. margaritarius (Trochoidea; Gastropoda)S T Williams, S Ito, K Wakamatsu, et al.
Administration and Policy in Mental Health|November 16, 2025
The Potential Role of Peer Support Workers in General Practice: Perspectives of Consumers, Carers, Peer Support Workers and General Practice StaffSharon Lawn, Megan Rattray, Belinda Fuss, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2025
Loss of apolipoprotein E contributes to inflammatory macrophage activation and ferroptosis in NSAID-exacerbated respiratory diseaseGilles Schmiz, Pascal Haimerl, Isika Ram, et al.
Plos One|March 3, 2012
Primitive duplicate Hox clusters in the European eel's genomeChristiaan V Henkel, Erik Burgerhout, Daniëlle L de Wijze, et al.
Allergy|April 4, 2024
Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID-exacerbated respiratory diseaseFranziska Hartung, Pascal Haimerl, Sonja Schindela, et al.
Molecular Therapy Oncolytics|July 11, 2018
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target SitesMathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, et al.
Brain, Behavior, & Immunity - Health|July 14, 2025
Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's diseaseBenjamin Siciliano, Nicholas D Henkel, William G Ryan V, et al.
Journal of Medicinal Chemistry|October 6, 2011
Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemiaRobert J Davies, Albert C Pierce, Cornelia Forster, et al.
Pageof 203